Eveline Van Keymeulen > Latham & Watkins > Paris, France > Lawyer Profile
Latham & Watkins Offices
45 RUE SAINT DOMINIQUE
75007 PARIS
France
- Firm Profile
- Go to...
Eveline Van Keymeulen
Position
Eveline Van Keymeulen is a partner in Latham & Watkins’ Brussels and Paris offices and Global Vice Chair of Latham & Watkins’ Healthcare & Life Sciences Practice.
She advises multinational companies and start-ups in the pharmaceutical, biotech, medical devices, cosmetics, and food and beverage sectors on a broad variety of complex European, domestic and cross-border regulatory matters, including clinical trials, product approvals, regulatory incentives, market access, promotion and advertising, post-market obligations, and general compliance matters.
In addition, Eveline has extensive experience advising on cannabis and hemp-based product regulations. She successfully challenged the legality of French hemp regulations in the first landmark case related to cannabidiol (CBD) products before the Court of Justice of the European Union (Case C-663/18, Kanavape). This transaction won the Creating New Standards award at the Financial Times European Innovative Lawyer Awards 2022.
Eveline has authored numerous articles and has been a featured speaker on EU regulatory matters at prominent conferences such as the Pharmaceutical Law Academy in Cambridge. She also serves on the editorial board of the European Pharmaceutical Law Review.
In addition, Eveline has been quoted in BBC Business Daily, Bloomberg, The Times, Les Echos, and other leading international business journals on life sciences regulatory and policy matters.
Lawyer Rankings
France > Industry focus: Healthcare and life sciences
(Next Generation Partners)The team at Latham & Watkins, praised for its ‘in-depth’ sector knowledge, particularly in relation to innovative technology in the medtech and biotech sectors. Praised by clients for her ‘mastery’ of EU regulation, Eveline Van Keymeulen heads the practice. Having deep knowledge spanning CBD regulatory issues, Van Keymeulen is well-placed to advise clients on cross-border regulatory matters. Jeanne Fabre advises numerous global biotech, medical device, and pharma companies on an array of regulatory issues, including market access, post-market obligations, and clinical trials.
Lawyer Rankings
- Next Generation Partners France > Industry focus: Healthcare and life sciences
- Industry focus: Healthcare and life sciences France
Top Tier Firm Rankings
- Banking and finance: transactional work
- EU, competition and distribution
- Insolvency
- Private equity: LBO
Firm Rankings
- Capital markets: debt capital markets
- Capital markets: equity capital markets
- Data privacy and data protection
- Derivatives and structured finance
- Mergers and acquisitions
- Tax
- Compliance
- Dispute resolution: Commercial litigation
- Dispute resolution: International arbitration
- Employment
- Industry focus: Healthcare and life sciences
- Industry focus: IT and internet
- Media and entertainment: Sports